IPO Details

Bidding Dates

17 May '23 - 19 May '23

Minimum Investment

₹122,900 / 1 Lots (100 Shares)

Price Range

₹1150 - ₹1229

Maximum Investment

₹122,900 / 1 Lots (100 Shares)

Retail Discount

Not Applicable

Issue Size

₹47.69 crore

Investor category and sub category

Qualified Institutional Buyers   |   Non-Institutional Investors  |   Retail Individual Investor   |  

IPO Dates

Important dates with respect to IPO allotment and listing

Opening Date

May 17, 2023

Closing Date

May 19, 2023

Basis of Allotment

May 24, 2023

Initiation of Refunds

May 25, 2023

Credit of Shares to Demat

May 26, 2023

Listing Date

May 29, 2023

UPI Mandatory Expiry Date

May 19, 2023

Remus Pharmaceuticals IPO Subscription Details


Day 1May 17, 2023

0.00 2.85 2.85 1.43

Day 2May 18, 2023

1.48 12.25 10.93 6.41

Day 3May 19, 2023

1.48 33.16 17.21 11.74

Remus Pharmaceuticals IPO Subscription Status Live

Investor Category Subscription (Times)
Qualified Institutions Buyer 1.48
Non-Institutional Buyers 33.16
Retail Investors 17.21
Employees [.]
Others [.]
Total 11.74

About Remus Pharmaceuticals Limited IPO

Remus Pharmaceuticals participates in the marketing and distribution of finished formulations of pharmaceutical drugs. Its business line can be classified into three major categories.

  • API marketing and distribution
  • Finished pharmaceutical drugs: marketing and distribution
  • Technical consultancy to prepare reports on pharmaceutical dossiers

Remus Pharma distributes to generic distributors, and regional and multinational distributors to hospitals and clinics through a responsive distribution channel. It caters to clients spread across twenty countries.

As on January 31, 2023, Remus Pharma had a product portfolio of 429 products that it sells under different brand names in different countries.

Remus Pharmaceuticals Limited IPO Details

The IPO contains only fresh issues worth Rs. 47.69. In the book-building IPO, the price band is fixed at Rs. 1150-1229 per share. The bidding window will open on May 17, 2023, for retail investors.

Remus Pharmaceuticals Limited IPO Objective

The net proceeds from the fresh issues will be utilised in the areas below.

  • Funding investment for an acquisition
  • General corporate purposes and working capital requirements
  • To meet the IPO expenses

Should you invest in Remus Pharmaceuticals Limited?

Here are a few key reasons to consider before investing in the IPO:

  • The company offers a diversified product portfolio to its customers spread across 20 countries.
  • Remus Pharma has a diversified business operation and revenue base.
  • It is engaged with contract manufacturers that are WHO and GMP-compliant.

Competitive Peers

The other players in the segment recognised by the company are Trident Lifeline, Vaishali Pharma, and Chandra Bhagat Pharma Ltd.

Noteworthy Highlights of Remus Pharmaceuticals Limited

  • The revenue from export has increased from Rs. 1,191.90 lakhs in FY 2020 to Rs. 2,316.23 lakhs in FY 2022.

IPO Financials

Particulars Period ending on December 31, 2022 Year ending on March 31, 2022 Year ending on March 31, 2021
Revenue from Operations 3,239.17 2,471.71 1,841.81
Profit After Tax (PAT) 643.90 338.57 102.58
PAT Margin 19.88% 13.70% 5.57%
EBITDA 916.17 479.07 156.82
EBITDA Margin 28.28% 19.38% 8.51%
ROE 54.68% 71.44% 40.49%

Know before investing


  1. It operates on a scalable business model.

  2. The promoters are experienced in the pharmaceutical industry.

  3. The company offers a wide product base of 429 products, with an additional 134 products in the process of registration in 16 countries.


  1. Dependency on suppliers and manufacturers can impact the company’s future business operations and financial performance.

  2. The company lacks brand awareness.

  3. The absence of steady cash flow and the non-availability of funds can impact the future performance and profitability of the business.

  • How to Apply in IPO
  • How to Check IPO Allotment Status

Login to Angel One App / Website & click on IPO

Select desired IPO & tap on "Apply"

Enter UPI ID, set quantity/price & submit

Accept mandate on the UPI app to complete the process

Login to Angel One App / Website

Choose IPO section on Home Page

Click IPO Orders

Chose the IPO application you want to view the status for

Remus Pharmaceuticals Limited IPO FAQs

What is Remus Pharmaceuticals Limited's IPO?

The Remus Pharmaceuticals Limited IPO consists of fresh issues worth Rs. 47.69 crore. The Remus Pharmaceuticals Limited IPO price band is fixed at Rs. 1150–1229 per share.

When will Remus Pharmaceuticals Limited's IPO allotment be available?

The Basis of Allotment date for Remus Pharmaceuticals Limited is May 24, 2023.

What will be Remus Pharmaceuticals Limited's IPO lot size?

Retail investors can apply for one lot with 100 shares.

When will Remus Pharmaceuticals Limited's IPO open for subscription?

The IPO bidding window will open on May 17, 2023.

What minimum lot size can retail investors subscribe to?

Retail investors can apply for a minimum of one lot.

When will Remus Pharmaceuticals Limited list on exchanges?

The Remus Pharmaceuticals Limited IPO will list on the exchange on May 29, 2023.

How do I check the allotment status of the Remus Pharmaceuticals Limited IPO?

You can check the Remus Pharmaceuticals Limited IPO allotment status on Angel One’s mobile app. Log in to the app using your registered mobile number and verification OTP. To check IPO shares’ allotment status, enter the application number, DP ID, and PAN number into the app to check the allotment status.

What would be the listing gains on the Remus Pharmaceuticals Limited IPO?

Listing gains can be ascertained on the day of listing the IPO on the stock exchange, which is May 29, 2023, in the case of Remus Pharmaceuticals Limited.

I have finished the application process for the Remus Pharmaceuticals Limited IPO, but the funds are not yet debited. What is the reason?

The bank will only block the amount in your account. The money will not be debited before the IPO shares are allotted.

How to approve the UPI mandate request for Remus Pharmaceuticals Limited IPO?

To approve the payment mandate, log in to your UPI handle. You will receive a payment request on the UPI payment platform. Approve the request.

Can I submit more than one application for the public issue of Remus Pharmaceuticals Limited using one PAN?

You can submit only one application using one PAN card.

What is the minimum order quantity for the Remus Pharmaceuticals Limited IPO?

The minimum order quantity is one lot with 100 shares.